Resultats de la cerca - Cheng‐Yuan Peng
- Mostrar 1 - 20 resultats de 35
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection per Qing Wang, Cheng‐Yuan Peng, Min Yang, Fengqi Huang, Xuzhuo Duan, Shaowen Wang, Huitao Cheng, Huirong Yang, Huihong Zhao, Qiwei Qin
Publicat 2021Artigo -
6
Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C per Sheng‐Hung Chen, Yufen Li, Hsueh‐Chou Lai, Jung‐Ta Kao, Cheng‐Yuan Peng, Po‐Heng Chuang, Wen‐Pang Su, I‐Ping Chiang
Publicat 2012Artigo -
7
Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels per Kuan‐Pin Su, Shih‐Yi Huang, Cheng‐Yuan Peng, Hsueh‐Chou Lai, Chieh‐Liang Huang, Yi-Chih Chen, Katherine J. Aitchison, Carmine M. Pariante
Publicat 2009Artigo -
8
-
9
-
10
Increased Incidence of Gastrointestinal Cancers Among Patients With Pyogenic Liver Abscess: A Population-Based Cohort Study per Hsueh‐Chou Lai, Che‐Chen Lin, Ken‐Sheng Cheng, Jung‐Ta Kao, Jen‐Wei Chou, Cheng‐Yuan Peng, Shih‐Wei Lai, Pei‐Chun Chen, Fung‐Chang Sung
Publicat 2013Artigo -
11
Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis per Ira M. Jacobson, Eric Lawitz, Paul Y. Kwo, Christophe Hézode, Cheng‐Yuan Peng, Anita Y. M. Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber
Publicat 2017Artigo -
12
New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis per Hung‐Wei Wang, Cheng‐Yuan Peng, Hsueh-Chou Lai, Wen-Pang Su, Chia‐Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen, Wei‐Fan Hsu, Guan‐Tarn Huang
Publicat 2017Artigo -
13
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents per Wei‐Fan Hsu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Po‐Heng Chuang, Sheng‐Hung Chen, Hung‐Yao Chen, Hung‐Wei Wang, Guan‐Tarn Huang, Cheng‐Yuan Peng
Publicat 2019Artigo -
14
Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir per Chien‐Hung Chen, Chuan-Mo Lee, Hsueh‐Chou Lai, Tsung‐Hui Hu, Wen-Pang Su, Sheng‐Nan Lu, Chia‐Hsin Lin, Chao‐Hung Hung, Jing‐Houng Wang, Mei–Hsuan Lee, Cheng‐Yuan Peng
Publicat 2017Artigo -
15
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study per Yun–Fan Liaw, M. Raptopoulou‐Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng‐Yuan Peng, Robert P. Myers, Robert S. Brown, Lennox J. Jeffers, Naoky Tsai, Jolanta Białkowska, Shijie Tang, S. P. Beebe, Elizabeth Cooney
Publicat 2011Artigo -
16
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan per Chen‐Hua Liu, Ming‐Lung Yu, Cheng‐Yuan Peng, Tsai‐Yuan Hsieh, Yi‐Hsiang Huang, Wei‐Wen Su, Pin‐Nan Cheng, Chih‐Lin Lin, Gin‐Ho Lo, Chi‐Yi Chen, Jyh‐Jou Chen, Qian Ma, C. Brooks-Rooney, Jia‐Horng Kao
Publicat 2018Artigo -
17
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion per Hung‐Chih Yang, Chi‐Ling Chen, Yueh-Chi Shen, Cheng‐Yuan Peng, Chun‐Jen Liu, Tai–Chung Tseng, Tung‐Hung Su, Wan‐Long Chuang, Ming‐Lung Yu, Chia‐Yen Dai, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Publicat 2012Artigo -
18
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection per Paul Y. Kwo, Edward Gane, Cheng‐Yuan Peng, Brian L. Pearlman, John M. Vierling, Lawrence Serfaty, Marı́a Buti, Stephen D. Shafran, Paul Stryszak, Lin Li, Jacqueline Gress, Stuart Black, Frank J. Dutko, Michael Robertson, Janice Wahl, Lisa Lupinacci, Eliav Barr, Barbara Haber
Publicat 2016Artigo -
19
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations per Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang
Publicat 2020Artigo -
20
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population per Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang
Publicat 2020Revisão
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Virus
Gastroenterology
Immunology
Virology
Hepatocellular carcinoma
Hepatitis B virus
Hepatitis C
Cirrhosis
Chronic hepatitis
Hepatitis B
Hepatitis C virus
Entecavir
Lamivudine
Biology
Confidence interval
HBsAg
Biochemistry
Hepatology
Oncology
Receiver operating characteristic
Environmental health
HBeAg
Hepatitis
Interferon
Pharmacology
Population
Randomized controlled trial
Ribavirin